Clinical evidence of the relationship between aspirin and breast cancer risk (Review)

  • Authors:
    • Nadia J. Jacobo-Herrera
    • Carlos Pérez-Plasencia
    • Elizabeth  Camacho‑Zavala
    • Gabriela Figueroa González
    • Eduardo López Urrutia
    • Verónica  García‑Castillo
    • Alejandro Zentella-Dehesa
  • View Affiliations

  • Published online on: June 13, 2014     https://doi.org/10.3892/or.2014.3270
  • Pages: 451-451
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

In the search for new therapeutic alternatives against cancer, either as a preventive treatment or for advanced stages, it is common to appeal to well-known drugs used for the treatment of other diseases that may interfere with the metabolic pathways involved in carcinogenesis. Non-steroidal anti-inflammatory drugs (NSAIDs) display anticancer activity through the inhibition of the COX-2 enzyme, triggering processes such as apoptosis, a reduction in proliferation and inhibition of carcinogenesis. Breast cancer is a neoplasm with the highest incidence and mortality rate among young women worldwide. Epidemiologic data have shown that drugs such as NSAIDs, particularly aspirin, reduce the relative risk of breast cancer. However, in the subgroup of responsive patients, dose, time and frequency of use have not yet been established. Here, we review the reports published during the last 10 years regarding the relationship between breast cancer and aspirin.
View Figures
View References

Related Articles

Journal Cover

August-2014
Volume 32 Issue 2

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Jacobo-Herrera NJ, Pérez-Plasencia C, Camacho‑Zavala E, González GF, Urrutia EL, García‑Castillo V and Zentella-Dehesa A: Clinical evidence of the relationship between aspirin and breast cancer risk (Review). Oncol Rep 32: 451-451, 2014
APA
Jacobo-Herrera, N.J., Pérez-Plasencia, C., Camacho‑Zavala, E., González, G.F., Urrutia, E.L., García‑Castillo, V., & Zentella-Dehesa, A. (2014). Clinical evidence of the relationship between aspirin and breast cancer risk (Review). Oncology Reports, 32, 451-451. https://doi.org/10.3892/or.2014.3270
MLA
Jacobo-Herrera, N. J., Pérez-Plasencia, C., Camacho‑Zavala, E., González, G. F., Urrutia, E. L., García‑Castillo, V., Zentella-Dehesa, A."Clinical evidence of the relationship between aspirin and breast cancer risk (Review)". Oncology Reports 32.2 (2014): 451-451.
Chicago
Jacobo-Herrera, N. J., Pérez-Plasencia, C., Camacho‑Zavala, E., González, G. F., Urrutia, E. L., García‑Castillo, V., Zentella-Dehesa, A."Clinical evidence of the relationship between aspirin and breast cancer risk (Review)". Oncology Reports 32, no. 2 (2014): 451-451. https://doi.org/10.3892/or.2014.3270